Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference
Wave Life Sciences: An Fairly Valued RNA Opportunity
Wave Life Sciences Ltd. (WVE) Presents at Bank of America SMID Cap Virtual Conference Transcript
Did U.S. Redomiciliation and Mixed 1H 2026 Results Just Shift Wave Life Sciences' (WVE) Investment Narrative?
Wave Life Sciences Announces Expected Completion Date for Redomiciliation to Delaware
Mizuho Maintains Outperform on WAVE Life Sciences, Lowers Price Target to $23
Wave Life Sciences to Present at Upcoming Investor Conferences
Wave Life Sciences (WVE) Q2 2026 Earnings Call Transcript
Citigroup Maintains Buy on WAVE Life Sciences, Lowers Price Target to $19
B. Riley Securities Maintains Buy on WAVE Life Sciences, Lowers Price Target to $22
Wedbush Maintains Outperform on WAVE Life Sciences, Lowers Price Target to $12
Wave Life Sciences Ltd. Q2 2026 Earnings Call Summary
WAVE Life Sciences Q2 Earnings Call Highlights
WAVE Life Sciences Ltd (WVE) (Q2 2026) Earnings Call Highlights: Strong Cash Position and ...
Wave Life Sciences Ltd. (WVE) Q2 2026 Earnings Call Transcript
Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates
Wave Life Sciences (NASDAQ:WVE) Plunges After Q2 Revenue Miss
Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update
WAVE Life Sciences Q2 EPS $(0.34) Misses $(0.31) Estimate, Sales $2.272M Miss $7.050M Estimate
Wave Life Sciences (WVE) Stock Looks Cheap On Price But Expensive On Sales
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.